{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T05:15:18Z","timestamp":1788498918262,"version":"build-2803163510"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>US-guided thermal ablation (TA) has shown favorable local control for cervical lymph node metastases (LNM) from papillary thyroid carcinoma (PTC), whereas outcomes appear less favorable for LNM from lung adenocarcinoma (LAC). The pathological basis underlying these differences remains unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To compare the pathological characteristics of cervical LNMs from PTC and LAC, focusing on proliferation- and invasion-related markers, and to explore potential biological factors associated with their distinct clinical behavior.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center retrospective study, cervical LNM specimens from patients with PTC or LAC were assessed by immunohistochemistry for Ki-67, PCNA, p53, and MMP-9. Marker expression in tumor cells was compared between groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 145 patients were included (PTC-N1a, n = 50; PTC-N1b, n = 50; LAC-LNM, n = 45). LAC-related lymph node metastases (LAC-LNM) showed significantly higher Ki-67, PCNA, p53, and MMP-9 staining intensity than both PTC subgroups (all overall P &amp;lt; 0.001). The proportion of MMP-9-positive tumor cells also differed among groups (P = 0.016). Within the PTC cohort, only Ki-67 expression was significantly higher in N1b than in N1a (P\u00a0=\u00a00.001). After adjustment for age and sex, LAC-LNM remained associated with higher Ki-67, PCNA, and p53 expression and greater MMP-9 staining intensity, whereas the difference in MMP-9-positive tumor cell proportion was no longer significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>LAC-LNM exhibited a more proliferative immunophenotype and greater MMP-9 staining intensity than PTC-LNM. These differences may contribute to their distinct clinical behavior.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1885180","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:24:32Z","timestamp":1788495872000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Pathological characteristics of cervical lymph node metastases in papillary thyroid carcinoma compared with lung adenocarcinoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Mei-Xuan","family":"Shao","sequence":"first","affiliation":[{"name":"Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Beijing, China"]},{"name":"Department of Interventional Medicine, China\u2013Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Pathology, China\u2013Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Interventional Medicine, China\u2013Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Long","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Interventional Medicine, China\u2013Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-An","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Interventional Medicine, China\u2013Japan Friendship Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1177\/0300060520984618","article-title":"A population-based study of the three major variants of papillary thyroid carcinoma","volume":"49","author":"Xu","year":"2021","journal-title":"J Int Med Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21653","article-title":"Clinically significant prognostic factors for differentiated thyroid carcinoma: a population-based, nested case-control study","volume":"106","author":"Lundgren","year":"2006","journal-title":"Cancer"},{"key":"B3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1186\/s12885-017-3698-2","article-title":"Skip metastasis in papillary thyroid carcinoma is difficult to predict in clinical practice","volume":"17","author":"Nie","year":"2017","journal-title":"BMC Cancer"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0039-6060(03)00424-0","article-title":"Role of preoperative ultrasonography in the surgical management of patients with thyroid cancer","volume":"134","author":"Kouvaraki","year":"2003","journal-title":"Surgery"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.240347","article-title":"2024 international expert consensus on US-guided thermal ablation for T1N0M0 papillary thyroid cancer","volume":"315","author":"Zhao","year":"2025","journal-title":"Radiology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1580765","article-title":"A clinical study of microwave ablation for cervical lymph node metastasis from papillary thyroid cancer","volume":"16","author":"Wu","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B7","article-title":"Ablation techniques in non-small cell lung cancer patients: experience of a single center","volume":"26","author":"Botsa","year":"2022","journal-title":"Hippokratia"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.21037\/tlcr-20-1075","article-title":"Thermal ablation in non-small cell lung cancer: a review of treatment modalities and the evidence for combination with immune checkpoint inhibitors","volume":"10","author":"Rangamuwa","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2025.2553205","article-title":"A preliminary comparative study of microwave ablation for cervical lymph node metastases originating from papillary thyroid carcinoma vs. non-papillary thyroid carcinoma","volume":"42","author":"Liu","year":"2025","journal-title":"Int J Hyperthermia"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1177\/10732748231155701","article-title":"The value of Ki-67 labeling index in central lymph node metastasis and survival of papillary thyroid carcinoma: evidence from the clinical and molecular analyses","volume":"30","author":"Lei","year":"2023","journal-title":"Cancer Control"},{"key":"B11","article-title":"Kank1 and Ki67 expression are associated with poor prognosis in human pulmonary adenocarcinoma","volume":"13","author":"Shen","year":"2020","journal-title":"Int J Clin Exp Pathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.lungcan.2021.02.009","article-title":"Tumor cell proliferation (Ki-67) expression and its prognostic significance in histological subtypes of lung adenocarcinoma","volume":"154","author":"Li","year":"2021","journal-title":"Lung Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2010.11.005","article-title":"Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma","volume":"15","author":"Tan","year":"2011","journal-title":"Ann Diagn Pathol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1096-9098(199901)70:1<45::aid-jso8>3.0.co;2-b","article-title":"Anaplastic transformation of papillary thyroid carcinoma in recurrent disease in regional lymph nodes: a histologic and immunohistochemical study","volume":"70","author":"Ozaki","year":"1999","journal-title":"J Surg Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3892\/ol.2010.219","article-title":"Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma","volume":"2","author":"Feng","year":"2011","journal-title":"Oncol Lett"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-008-9756-9","article-title":"Clinical significance of p53 protein expression in papillary thyroid carcinoma","volume":"32","author":"Morita","year":"2008","journal-title":"World J Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.cllc.2023.12.004","article-title":"Prognostic impact of TP53 mutations in metastatic nonsquamous non-small-cell lung cancer","volume":"25","author":"Mathiot","year":"2024","journal-title":"Clin Lung Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2016.1057","article-title":"TP53 mutation is associated with a poor clinical outcome for non-small cell lung cancer: evidence from a meta-analysis","volume":"5","author":"Gu","year":"2016","journal-title":"Mol Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pathol.2018.10.008","article-title":"MMP-9-1562 C\/T single nucleotide polymorphism associates with increased MMP-9 level and activity during papillary thyroid carcinoma progression","volume":"51","author":"Roncevic","year":"2019","journal-title":"Pathology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7956","DOI":"10.3390\/ijms26167956","article-title":"Inhibition of metalloproteinases-2, -9, and -14 suppresses papillary thyroid carcinoma cell migration and invasion","volume":"26","author":"Rocco","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4238\/2015.December.29.44","article-title":"Correlation between matrix metalloproteinase-9 and vascular endothelial growth factor expression in lung adenocarcinoma","volume":"14","author":"Wen","year":"2015","journal-title":"Genet Mol Res"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1885180\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T04:24:33Z","timestamp":1788495873000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1885180\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":21,"alternative-id":["10.3389\/fonc.2026.1885180"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1885180","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"article-number":"1885180"}}